A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested that with inflation risks moderating and unemployment remaining low, the Federal Reserve might consider a shift in its monetary policy stance, including potential interest rate cuts. This outlook eased market concerns about prolonged high interest rates and their impact on economic growth. The prospect of lower borrowing costs bolstered investor confidence, particularly in sectors that have lagged, leading to a broad rally across the market.
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names.
But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
A number of stocks fell in the afternoon session after the major indices continued to pull back, with technology stocks accounting for most of the market's largest decliners. A key reason for this trend is that much of the recent market gains were concentrated in the "AI trade," which includes these large technology and semiconductor companies. So this could also mean that some investors are locking in some gains ahead of more definitive feedback from the Fed.
Shares of health insurance company Oscar Health (NYSE:OSCR) jumped 7.1% in the morning session after continued positive momentum as it announced a partnership to launch a new health insurance plan with grocery chain Hy-Vee.
Health insurance company Oscar Health (NYSE:OSCR) fell short of the market’s revenue expectations in Q2 CY2025, but sales rose 29% year on year to $2.86 billion. Its non-GAAP loss of $0.89 per share was 6.5% below analysts’ consensus estimates.
Health insurance company Oscar Health (NYSE:OSCR) fell short of the market’s revenue expectations in Q2 CY2025, but sales rose 29% year on year to $2.86 billion. Its GAAP loss of $0.89 per share was in line with analysts’ consensus estimates.
